Biogen Inc. vs Ingersoll Rand Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Biogen Inc.
$30.9B
μμ #301
Ingersoll Rand Inc.
$31.9B
μμ #299
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Ingersoll Rand Inc.μ΄(κ°) 2024λ κΉμ§ Biogen Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Biogen Inc. | Ingersoll Rand Inc. | μ λ |
|---|---|---|---|
| 2026 | $30.9B | $31.9B | Ingersoll Rand Inc. |
| 2025 | $26.0B | $31.0B | Ingersoll Rand Inc. |
| 2024 | $22.6B | $35.3B | Ingersoll Rand Inc. |
| 2023 | $38.2B | $30.2B | Biogen Inc. |
| 2022 | $40.9B | $20.4B | Biogen Inc. |
| 2021 | $35.4B | $24.1B | Biogen Inc. |
| 2020 | $36.2B | $17.7B | Biogen Inc. |
| 2019 | $43.8B | $14.0B | Biogen Inc. |
| 2018 | $44.4B | $7.4B | Biogen Inc. |
| 2017 | $47.0B | $12.3B | Biogen Inc. |